Status:
COMPLETED
A Safety Extension Study of DR-OXY-301
Lead Sponsor:
Duramed Research
Conditions:
Overactive Bladder
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
This is a safety extension study of DR-OXY-301 at pre-selected sites. Subjects who complete the DR-OXY-301 study are eligible to participate. The duration of this extension study will be up to approxi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Completed the 12 weeks of treatment in the DR-OXY-301 study
- Willing to limit medications for overactive bladder to investigational product only
- Able to understand and complete all study procedures including the required diary
Exclusion
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00782769
Start Date
September 1 2008
End Date
July 1 2010
Last Update
March 16 2023
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
Duramed Investigational Site
Phoenix, Arizona, United States, 85015
2
Duramed Investigational Site
San Diego, California, United States, 92103
3
Duramed Investigational Site
San Diego, California, United States, 92108
4
Duramed Investigational Site
Miami, Florida, United States, 33143